specific considerations for monoclonal antibody treatment in nmosd
Published 1 year ago • 59 plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
52:12
cmsc 2020 day 1: brian weinshenker, md on nmosd: emerging treatment options
-
3:20
kathleen hawker, md: clinical findings for satralizumab in treating nmosd
-
0:44
what is a monoclonal antibody?!
-
4:56
eculizumab: a review in neuromyelitis optica spectrum disorder
-
5:44
diagnostic criteria and treatment updates for nmosd
-
3:20
how monoclonal antibodies treat cancer
-
1:00
monoclonal antibody therapy: covid-19 treatment
-
0:16
what are the common development challenges in therapeutic monoclonal antibodies treatment
-
4:38
benefits of monoclonal antibody treatment
-
3:11
anti-c5 mab eculizumab highly efficacious for the treatment of aqp4-positive nmosd
-
3:33
in-depth: what are monoclonal antibodies and how do they work?
-
0:16
what are the common development challenges in therapeutic monoclonal antibodies treatment
-
3:08
who's eligible for monoclonal antibody therapy?
-
6:06
monoclonal antibody therapy | immunotherapy | immunity | basic science series
-
4:54
monoclonal antibody combinations in all
-
0:59
what is monoclonal antibody therapy and how does it work?
-
4:57
ask a researcher: monoclonal antibodies
-
2:34
monoclonal antibody therapies: what healthcare providers need to know.
-
1:17
combination approaches in the treatment of nmosd